Paul Calabresi Program in Clinical-Translational Research

About this program

The Paul Calabresi Program, funded by the National Cancer Institute and hosted by the Mayo Clinic, offers an extensive training opportunity for clinicians and researchers to specialize in clinical-translational therapeutic oncology. Scholars receive 75% protected time for research and training over two or more years, with a focus on translational research, clinical trials, and basic research. Eligibility is restricted to U.S. citizens, permanent residents, or noncitizen nationals, with specific requirements for medical doctors and Ph.D. applicants, including relevant clinical training and postdoctoral research experience.